Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DataMed is a specialized medical technology company that provides vendor-neutral ECG (electrocardiogram) data management and integration solutions. The company's flagship platform, DataMed FT, serves as a critical bridge between various cardiac diagnostic devices and hospital electronic medical record (EMR) systems, ensuring seamless data flow regardless of the hardware manufacturer. By centralizing and standardizing ECG data, DataMed enables healthcare providers to improve clinical efficiency, reduce manual data entry errors, and accelerate the time to diagnosis for cardiac patients. In addition to its hospital solutions, the company provides specialized ECG management services for clinical trials in the pharmaceutical and biotechnology industries. In January 2023, DataMed was acquired by GE HealthCare to strengthen its digital health portfolio and expand its capabilities in integrated cardiology care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DataMed Devices.